Harvard Bioscience Announces Q3 2025 Earnings Release and Conference Call on November 6, 2025.

Harvard Bioscience will announce Q3 2025 earnings on November 6, 2025, before the market opens. The company will hold a conference call at 8:00 AM ET to discuss the results. Participants must register to join the call and ask questions. Financial information and a related slide presentation will be available on the company's website. Harvard Bioscience develops, manufactures, and sells technologies, products, and services for life science applications, including research, pharmaceutical and therapy discovery, bio-production, and preclinical testing.